
Celgene has been dealt a heavy blow, revealing that the FDA has rejected its New Drug Application for its sphingosine …

Celgene has boosted its immune and inflammatory disease pipeline with the purchase of the biopharma company Receptos for $7.2 billion. …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

